PRODUCT LITERATURE

Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis: A Randomized Trial

---

The current standard initial therapies for deep venous thrombosis are low-molecular-weight heparin and unfractionated heparin. In a dose-ranging study of patients with symptomatic deep venous thrombosis, fondaparinux had efficacy and a safety profile similar to those of low-molecular-weight heparin
(dalteparin)

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Diviti
Fondaparinux
Deep Venous Thrombosis

Specific Detail Info

Ann Intern Med. 2004;140:867-873

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment